UnitedHealth Faces Rising Uncertainty Amid CEO Change and Guidance Withdrawal
UnitedHealth Group stock falls sharply as CEO changes and 2025 guidance withdrawal increase uncertainty. Analysis of implications for the health insurance market.
UnitedHealth Downgraded to Neutral Amid Medicare Advantage Challenges
UnitedHealth downgraded to Neutral by BofA after suspending 2025 guidance due to Medicare Advantage challenges. Analyst price targets and ratings vary amid uncertainty.
UnitedHealth Faces Securities Lawsuit Following Q1 Results and Guidance Cut
UnitedHealth Group faces a securities class action lawsuit after slashing 2025 earnings guidance and reporting Q1 losses, raising issues on Medicare Advantage utilization and corporate disclosures.
UnitedHealth Group Spends $1.7M on Executive Security Post-CEO Death
UnitedHealth Group allocated $1.7 million for executive security following the death of UnitedHealthcare CEO Brian Thompson. The high-profile incident highlights executive safety and corporate governance in the health insurance sector.
UnitedHealth Reports Q1 Earnings Miss, Stock Takes Historic Tumble
Discover why UnitedHealth Group's stock experienced its largest decline in over 20 years following Q1 earnings that fell short of Wall Street expectations. Learn more about the factors influencing its financial performance and future outlook.
Medicare Advantage Plans Earn $33 Billion More in 2021
An analysis shows Medicare Advantage plans earned $33 billion more than Traditional Medicare in 2021 through coding differences. UnitedHealth Group received the largest share.